Navigation Links
Growth hormone is not the anti-aging bullet for healthy adults

A review of published data on use of human growth hormone (GH) by healthy elderly people found that the synthetic hormone was associated with small changes in body composition but not in body weight or other clinically important outcomes.

Further, people who took GH had increased rates of unhealthy side effects such as soft tissue swelling, joint pain, carpal tunnel syndrome, and, in men, abnormal breast development. They were also somewhat more likely to develop diabetes.

The review, "The Safety and Efficacy of Growth Hormone in the Healthy Elderly," was published in the Jan. 16, 2007, issue of Annals of Internal Medicine and is available on the Web at www.annals.org on that day.

"Growth hormone has been widely promoted as an anti-aging therapy," said Hau Liu, MD, a research fellow in endocrinology and health policy at Stanford University and an author of the review.

"But the scant clinical experience of GH in the healthy elderly suggests that although GH may minimally alter body composition, it does not improve other clinically relevant outcomes such as bone density, cholesterol levels, stamina, and longevity in this population.

"And it's associated with high rates of adverse events.

"So, on the basis of available evidence, we cannot recommend growth hormone use for anti-aging in the healthy elderly."

Human growth hormone, a protein produced by the pituitary gland, helps regulate growth during childhood and metabolism in adults.

In the United States, the FDA has approved the drug, now produced synthetically, to treat children with short stature and some other growth problems caused by childhood diseases.

The FDA has approved GH to treat adults with growth hormone deficiency syndrome. Its use for anti-aging falls into a grey area. The FDA prohibits drug companies from marketing GH for off-label uses such as anti-aging.

Yet tho usands of adults use GH as an anti-aging drug. One estimate is that 20,000 to 30,000 adults used it for anti-aging purposes in the United States in 2004.

The Web is replete with ads for all kinds of products said to contain GH, from pills, sprays, injections, secretagogues, homeopathic formations, and GH releasers and enhancers. GH, often in conjunction with vitamins, testosterone and other hormones, is said to increase muscle strength and mass, decrease body fat, improve mood and motivation, increase exercise capacity, increase bone density and (wink, wink) make wives and girlfriends happy.

Despite these enticing claims, careful review of existing evidence does not support the prescription of GH for anti-aging purposes.

Growth hormone is among the most expensive of all hormones used for replacement therapy. One physician estimated that a year's supply for an adult with GH-deficiency caused by pituitary disease would cost between $7,500 and $10,000 per year. Estimates of the cost of GH for anti-aging purposes range from $1,000 per month to $2,000 per month.

"Everyone is looking for the fountain of youth," Liu said. "We wanted to see if there is any validity behind some of the claims made about growth hormone's anti-aging properties.

"Our biggest surprise was the general lack of research that had been done in this area. When we reviewed the scientific evidence, we found that there were really only about 500 patients involved in rigorous controlled trials. And only a few more than 200 actually received growth hormone.

"Think about all the scientific claims made on anti-aging Web sites based on this small population of patients. The FDA typically doesn't approve a drug until it's been tested in thousands of patients.

"In our review, we found that growth hormone increased lean body mass or muscle mass by slightly more than two kilograms (that's a little over four pounds) and decreased fat mass by abo ut two kilograms. But it had no other beneficial effects that we could see.

"If you went to a gym pretty regularly, you might get that change without breaking into too much of a sweat, and you wouldn't spend $1,000 to $2,000 a month on something that appears to have modest or minimal benefit and the probability of bad side effects," said Liu.
'"/>

Source:American College of Physicians


Related biology news :

1. Growth in the sea comes down to a struggle for iron
2. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
3. Growth in biomass could put US on road to energy independence
4. Embryonic Stem Cells Treated With Growth Factor Reverse Hemophilia In Mice: UNC Researchers
5. Missing Receptor Molecule Causes Tumor Growth
6. Growth hormone is made in the brain, report scientists
7. Growth factor-promoting angiogenesis expressed in tumor cells and normal neurons
8. New Research Shows Artificial Light at Night Stimulates Breast Cancer Growth in Laboratory Mice
9. Growth factor stimulates rapid extension of key motor neurons in brain
10. Growth hormone to boost athletic performance risks diabetes
11. Female sex hormones play a vital role in defense against sexually transmitted diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... 2016 The report "Biometric Vehicle ... Technology (Iris Recognition System), Vehicle Type (Passenger Car, ... to 2021", published by MarketsandMarkets, the market is ... and is projected to grow to USD 854.8 ...      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH ... new partnership initiative targeting national brands, industry thought-leaders ... reward their respective audiences for taking steps to ... its inception in 2012, higi has built the ... impacting over 38 million people who have conducted ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... Francisco, CA (PRWEB) , ... ... ... leader uBiome is opening applications to an early access program for SmartBiome ... of metagenomic deep-sequencing with the simultaneous specific enrichment and detection of hundreds ...
(Date:12/6/2016)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), today ... fiscal year ended September 30, 2016. ... , , SQI ... company that develops and commercializes proprietary technologies and products for advanced ... revenues of $1.4 million more than tripling prior years revenue. ...
(Date:12/6/2016)... ... ... Discovering new clues to natural treatments that could allow our bodies to ... And searching for keys to our immune systems by studying parasite-resistant fish. These are ... Edith and Peter O’Donnell Awards by The Academy of Medicine, Engineering and ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... Point Partners ("GPP") portfolio company, today announced it has acquired the assets ... subsidiary of Chiltern International and focuses on clinical trial drug packaging, labeling, ...
Breaking Biology Technology: